Clinical Trials on Muscular Dystrophies in Japan
Total 1112 results
-
Taiho Pharmaceutical Co., Ltd.Completed
-
National Center of Neurology and Psychiatry, JapanNippon Shinyaku Co., Ltd.Completed
-
National Center of Neurology and Psychiatry, JapanNippon Shinyaku Co., Ltd.Completed
-
Nippon Shinyaku Co., Ltd.Active, not recruiting
-
Tohoku UniversityCompletedHereditary Inclusion Body Myopathy | Nonaka MyopathyJapan
-
Cooperative International Neuromuscular Research...United States Department of DefenseCompletedDuchenne Muscular Dystrophy | Becker Muscular Dystrophy | Limb Girdle Muscular DystrophyUnited States, Japan, Canada
-
Taiho Pharmaceutical Co., Ltd.RecruitingDuchenne Muscular DystrophyJapan
-
Suzuka HospitalNagoya UniversityUnknownCardiomyopathies | Duchenne Muscular DystrophyJapan
-
Daiichi Sankyo Co., Ltd.Orphan Disease Treatment Institute Co., Ltd.Completed
-
Daiichi Sankyo Co., Ltd.Active, not recruitingDuchenne Muscular DystrophyJapan
-
Kobe UniversityNobelpharma; Japan Medical AssociationUnknownMuscular Dystrophy, DuchenneJapan
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Newcastle-upon-Tyne Hospitals NHS TrustJain FoundationActive, not recruitingDysferlinopathy | LGMD2B Now Classified as LGMDR2 | Miyoshi MyopathyKorea, Republic of, Chile, Spain, United States, Denmark, France, Italy, Japan, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingBiallelic RPE65 Mutation-associated Retinal DystrophyJapan
-
NobelpharmaCompletedGNE Myopathy | Nonaka Disease | Distal Myopathy With Rimmed Vacuoles (DMRV) | Hereditary Inclusion Body Myopathy (hIBM)Japan
-
Astellas Pharma IncCompleted
-
Janssen Pharmaceutical K.K.CompletedX-Linked Retinitis PigmentosaJapan
-
Astellas Pharma IncCompleted
-
Janssen Pharmaceutical K.K.RecruitingX-Linked Retinitis PigmentosaJapan
-
PfizerTerminatedDuchenne Muscular DystrophyUnited States, Canada, United Kingdom, Japan, Italy
-
NS Pharma, Inc.Nippon Shinyaku Co., Ltd.Active, not recruitingDuchenne Muscular DystrophyKorea, Republic of, Chile, Japan, China, United Kingdom, Netherlands, Spain, Norway, Russian Federation, Australia, Greece, Italy, New Zealand, Turkey, Mexico, Czechia, Canada
-
Sarepta Therapeutics, Inc.Hoffmann-La RocheRecruitingDuchenne Muscular DystrophyBelgium, United States, Japan, Spain, Italy, United Kingdom
-
PfizerTerminatedDuchenne Muscular DystrophyUnited States, Australia, Canada, United Kingdom, Japan, Bulgaria, Italy, Poland
-
BioMarin PharmaceuticalNo longer availableDuchenne Muscular DystrophyUnited States, Germany, United Kingdom, Japan, Netherlands, France, Spain, Korea, Republic of, Italy, Belgium, Taiwan, Argentina, Australia, Bulgaria, Czechia, Israel, Norway, Poland, Russian Federation, Turkey
-
Sarepta Therapeutics, Inc.Hoffmann-La RocheActive, not recruitingDuchenne Muscular DystrophyUnited States, Japan, Taiwan, Belgium, Spain, Germany, Hong Kong, Italy, United Kingdom
-
Hoffmann-La RocheCompletedDuchenne Muscular DystrophyUnited States, Belgium, Canada, Australia, Japan, France, Netherlands, Spain, Argentina, Germany, Italy, United Kingdom, Sweden
-
PfizerActive, not recruitingDuchenne Muscular DystrophyUnited States, Spain, Belgium, Korea, Republic of, Taiwan, Canada, Australia, Germany, Japan, France, Italy, United Kingdom, Russian Federation, Israel, Switzerland
-
GlaxoSmithKlineCompletedMuscular DystrophiesFrance, Denmark, Germany, Belgium, Spain, Turkey, Korea, Republic of, Brazil, Netherlands, Italy, Chile, Japan, Canada, Hungary, Russian Federation, Czechia, Poland, Norway, Argentina, Taiwan
-
Eli Lilly and CompanyTerminatedMuscular Dystrophy, DuchenneGermany, United States, Spain, Belgium, France, Italy, Taiwan, Netherlands, Turkey, Korea, Republic of, Argentina, Canada, Japan, Puerto Rico, Russian Federation, United Kingdom
-
Kyoto University, Graduate School of MedicineNovartisUnknown
-
GlaxoSmithKlineTerminatedMuscular DystrophiesFrance, Bulgaria, Denmark, Germany, Belgium, Canada, Spain, Turkey, United Kingdom, Korea, Republic of, Brazil, Netherlands, Italy, Japan, Czech Republic, Chile, Israel, Hungary, Russian Federation, Australia, Poland, Norway, Argentina and more
-
Tokyo Medical UniversityUnknownCentral Retinal Vein Occlusion | Macular Edema | Branch Retinal Vein OcclusionJapan
-
Nagoya City UniversityNovartisCompletedBranch Retinal Vein OcclusionJapan
-
Mie UniversityUnknownCentral Retinal Vein OcclusionJapan
-
University of TokushimaMinistry of Health, Labour and Welfare, JapanUnknownLower Limb Spasticity After StrokeJapan
-
PTC TherapeuticsCompletedNervous System Diseases | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Muscular Diseases | Neuromuscular Diseases | Muscular Dystrophies | Muscular Disorders, Atrophic | Muscular Dystrophy, Duchenne | Musculoskeletal DiseaseUnited States, Taiwan, India, Korea, Republic of, Thailand, Australia, Brazil, Bulgaria, Canada, China, Hong Kong, Malaysia, Mexico, Poland, Puerto Rico, Russian Federation, Turkey, Japan
-
Santen Pharmaceutical Co., Ltd.CompletedMacular Edema Following Branch Retinal Vein OcclusionJapan, Korea, Republic of
-
Mie UniversityUnknownExudative Age-related Macular DegenerationJapan
-
Daiichi Sankyo Co., Ltd.CompletedFibrodysplasia Ossificans ProgressivaJapan
-
TakedaRecruitingSpinal and Bulbar Muscular AtrophyJapan
-
Kyoto University, Graduate School of MedicineKyoto Prefectural University of MedicineWithdrawnHypertension | Cardiovascular Disease | Vascular DiseaseJapan
-
Santen Pharmaceutical Co., Ltd.CompletedDiabetic Macular EdemaJapan
-
Kyowa Kirin Co., Ltd.TerminatedHealthy Volunteers | Wet Age-related Macular DegenerationJapan
-
Nagoya City UniversityNovartisCompletedNeovascular Age-related Macular DegenerationJapan
-
Kyoto University, Graduate School of MedicineRecruiting
-
Kumamoto UniversityCompletedAge-related Macular DegenerationJapan
-
Boehringer IngelheimRecruiting
-
Showa UniversityCompletedto Compare the Effect of Two Types of IOLs | on the Incidence of Cystoid Macular Edema | After Cataract SurgeryJapan
-
NovartisCompleted
-
Kagawa UniversityNovartis PharmaceuticalsCompleted